Erlotinib

Erlotinib

C004/8946 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 24.7MB

Downloadable file size: 927.0KB

Price image Pricing

Please login to use the price calculator


Credit: KENNETH EWARD/SCIENCE PHOTO LIBRARY

Caption: Erlotinib is an anticancer drug effective against small cell lung cancer, pancreatic cancer, and other cancers in which epidermal growth factor receptor (EGFR) is overexpressed. It works by binding to the active site of EGFR to inhibit its action, as in this image (EGFR is the large blue object surrounding erlotinib). Erlotinib is marketed by Roche under the trade name Tarceva.

Release details: Model release not required. Property release not required.

Keywords: animation, artwork, cancer, cancer drug, cancer medicine, cancer therapy, cgi, chemotherapeutic, digital, digitally generated, drawing, drug, egfr, erlotinib, graphic, illustration, medical, medicine, model, molecular, molecule, pharmeceutical, receptor, science, scientific, tarceva, therapy, treat, treatment

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.